Progyny price to book ratio PGNY
Market value divided by the book value of the company's net assets, since 2020.
- Today, Nov 2, 2026
- 5.0×
- 7-year median
- 8.0×
- Against its 7-year history
- 36th
- percentile: 0 is its lowest day, 100 its highest
- 7-year range
- 2.6× to 34.5×
- Peer median
- 3.0×
Progyny's price to book ratio is 5.0× as of Nov 2, 2026.
That is below its 7-year median of 8.0×, close to the middle of its last 7 years.
Over that time it ranged from 2.6× in Apr 2026 to 34.5× in Feb 2021.
The median for 10 hospital and care facility stocks of a similar size is 3.0×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 5.0× | 2.6× | 5.7× |
| 2025 | 4.0× | 3.1× | 4.7× |
| 2024 | 3.3× | 2.7× | 7.6× |
| 2023 | 6.9× | 5.6× | 9.5× |
| 2022 | 8.3× | 8.2× | 18.8× |
| 2021 | 20.3× | 18.9× | 34.5× |
| 2020 | 28.9× | 13.0× | 28.9× |
Against its peers
Companies in Medical - Care Facilities nearest Progyny's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| PGNYProgyny | 5.0× |
| ADUSAddus HomeCare | 2.0× |
| MDPediatrix Medical | 2.8× |
| PRVAPrivia Health | 3.5× |
| AVAHAveanna Healthcare | 10.0× |
| HCSGHealthcare Services | 3.3× |
| ARDTArdent Health | 1.2× |
| NHCNational Healthcare | 2.8× |
| PNTGPennant | 3.9× |
| USPHU S Physical Therapy | 2.8× |
| OMDAOmada Health | 4.3× |
| Peer median | 3.0× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Progyny
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.